California
Ortho Evra Patch Lawyers
Since 1978, the drug litigation attorneys at Bisnar & Chase
have been successfully representing clients who have suffered
as the result of dangerous prescription drugs, such as the
Ortho Evra birth control patch. The aggressive Ortho Evra
side effects lawyers have experience representing clients
throughout the country who have been injured by dangerous
prescription drugs, medical devices, and dietary supplements.
If you have suffered from blood clots, or any serious side
effect associated with Ortho Evra, contact Bisnar & Chase
right away to ensure that your rights are protected. Call
today for a free consultation.
Ortho Evra Birth Control Patch-In the News
Drug maker issues warning about birth-control patch
November 11, 2005
The Food and Drug Administration warned users of the popular
Ortho Evra birth control patch that they are being exposed
to more hormones, and are therefore at higher risk of blood
clots and other serious side effects, than previously disclosed.
Until now, regulators and patch-maker Ortho McNeil, a Johnson
and Johnson subsidiary, had maintained the patch was expected
to be associated with similar risks as the pill. But a strongly
worded warning was added to the patch label Thursday that
says women using the patch will be exposed to about 60 percent
more estrogen than those using typical birth control pills.
To read the entire article click
here.
FDA warns about Ortho Evra patch
November 11, 2005
WASHINGTON (Reuters) - Johnson & Johnson's Ortho Evra contraceptive
patch contains higher levels of a hormone known to cause blood
clots than average birth control pills, U.S. regulators warned
on Thursday.
To read the entire article click
here.
Warning issued for Ortho Evra birth control patch
What happened: On Nov. 11, 2005, the Food and Drug Administration
(FDA) announced a revision to the label for Ortho Evra, the
key ingredient in the birth control patch, warning women that
they were being exposed to a higher level of estrogen than
previously thought. The FDA cautions that exposure to higher
levels of estrogen may put Ortho Evra users at increased risk
of blood clots and other serious side effects.
To read the entire article click
here.
New Prescribing Information Announced for ORTHO EVRA Birth
Control Patch
November 10, 2005
RARITAN, N.J., Nov. 10 /PRNewswire/ -- Ortho Women's Health,
a unit of Ortho-McNeil Pharmaceutical, Inc., has updated the
WARNINGS section of the prescribing information for ORTHO
EVRA(R) (norelgestromin/ethinyl estradiol transdermal system)
as follows:
To read the entire article click
here.
FDA says patch has blood clot risk
November 11, 2005
WASHINGTON (CNN) - The Food and Drug Administration on Thursday
warned millions of women who use the Ortho Evra contraceptive
patch that they are being exposed to about 60 percent more
estrogen than with a typical birth control pill, which could
put them at higher risk for blood clots.
The labels on the medication will be updated with the warning,
the FDA said. Most daily birth control pills contain 35 micrograms
of estrogen.
To read the entire article click
here.
FDA Updates Labeling for Ortho Evra Contraceptive Patch
November 10, 2005
The Food and Drug Administration today approved updated labeling
for the Ortho Evra contraceptive patch to warn healthcare
providers and patients that this product exposes women to
higher levels of estrogen than most birth control pills. Ortho
Evra was the first skin patch approved for birth control.
It is a weekly prescription patch that releases ethinyl estradiol
(an estrogen hormone) and norelgestromin (a progestin hormone)
through the skin into the blood stream. FDA advises women
to talk to their doctor or healthcare provider about whether
the patch is the right method of birth control for them.
To read the entire article click
here.
If you or a loved one has experienced the
dangerous side effects of the Ortho Evra birth control patch,
please contact an Ortho Evra Side Effects Attorney at Bisnar
& Chase immediately.
|
